Help Troubleshoot Med Regimens for HFrEF

September 2024

Your skills will be needed to help fine-tune discharge meds for patients with heart failure with reduced ejection fraction (HFrEF).

Optimized meds reduce the risk of mortality and hospitalization. A hospital admission can be a key opportunity to improve HFrEF regimens.

But fewer than 1 in 6 patients get guideline-recommended “quad therapy” with an ACEI, ARB, or sacubitril/valsartan (Entresto)...an evidence-based beta-blocker (carvedilol, etc)...an aldosterone antagonist...plus an SGLT2 inhibitor (dapagliflozin, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote